JP2018523660A5 - - Google Patents

Download PDF

Info

Publication number
JP2018523660A5
JP2018523660A5 JP2018505617A JP2018505617A JP2018523660A5 JP 2018523660 A5 JP2018523660 A5 JP 2018523660A5 JP 2018505617 A JP2018505617 A JP 2018505617A JP 2018505617 A JP2018505617 A JP 2018505617A JP 2018523660 A5 JP2018523660 A5 JP 2018523660A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
phosgene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018505617A
Other languages
English (en)
Japanese (ja)
Other versions
JP6979398B2 (ja
JP2018523660A (ja
Filing date
Publication date
Priority claimed from GBGB1513979.3A external-priority patent/GB201513979D0/en
Priority claimed from PCT/GB2015/052291 external-priority patent/WO2016020698A1/en
Application filed filed Critical
Publication of JP2018523660A publication Critical patent/JP2018523660A/ja
Publication of JP2018523660A5 publication Critical patent/JP2018523660A5/ja
Application granted granted Critical
Publication of JP6979398B2 publication Critical patent/JP6979398B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018505617A 2015-08-07 2016-08-05 ベンゾジアゼピン誘導体の合成 Active JP6979398B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBPCT/GB2015/052291 2015-08-07
GBGB1513979.3A GB201513979D0 (en) 2015-08-07 2015-08-07 Synthesis of benzodiazepine derivatives
GB1513979.3 2015-08-07
PCT/GB2015/052291 WO2016020698A1 (en) 2014-08-08 2015-08-07 Benzodiazepine derivatives as cck2/gastrin receptor antagonists
PCT/GB2016/052442 WO2017025727A1 (en) 2015-08-07 2016-08-05 Synthesis of benzodiazepine derivatives

Publications (3)

Publication Number Publication Date
JP2018523660A JP2018523660A (ja) 2018-08-23
JP2018523660A5 true JP2018523660A5 (https=) 2019-07-25
JP6979398B2 JP6979398B2 (ja) 2021-12-15

Family

ID=54200391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018505617A Active JP6979398B2 (ja) 2015-08-07 2016-08-05 ベンゾジアゼピン誘導体の合成

Country Status (6)

Country Link
US (3) US10570102B2 (https=)
EP (2) EP3331865B1 (https=)
JP (1) JP6979398B2 (https=)
CN (1) CN108055843A (https=)
GB (1) GB201513979D0 (https=)
WO (1) WO2017025727A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107162923B (zh) * 2017-06-12 2019-04-23 浙江新三和医药化工股份有限公司 一种邻氨基苯乙酮的制备方法
WO2020148352A1 (en) 2019-01-17 2020-07-23 F. Hoffmann-La Roche Ag A process for the preparation of tetrahydropyridopyrimidines

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138433A (en) * 1975-06-26 1979-02-06 Hoechst Aktiengesellschaft Process for preparing 1,2-oxa-phospholanes
US4081455A (en) * 1976-06-02 1978-03-28 Pfizer Inc. 6-Amino-2,2-dimethyl-3-cyanopenams
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4820834A (en) 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
CA2032226A1 (en) 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
US4994258A (en) 1990-03-05 1991-02-19 Merck & Co., Inc. Gamma emitting, CCK-A antagonists for pancreatic imaging
CA2056809A1 (en) 1990-12-07 1992-06-08 Mark G. Bock Benzodiazepine analogs
US5218114A (en) 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists
FR2682381B1 (fr) * 1991-10-10 1995-04-07 Rhone Poulenc Rorer Sa Derives de benzodiazepine, leur preparation et les medicaments les contenant.
WO1993008175A1 (en) * 1991-10-24 1993-04-29 Glaxo Group Limited Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin
CN1074216A (zh) * 1991-10-24 1993-07-14 格拉克索公司 尿素衍生物
IL104853A (en) * 1992-02-27 1997-11-20 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
GB2264492B (en) * 1992-02-27 1996-09-25 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
EP0637308A1 (en) 1992-03-16 1995-02-08 MERCK SHARP & DOHME LTD. Benzodiazepine derivatives, compositions containing them and their use in therapy
JPH08508743A (ja) 1993-04-15 1996-09-17 グラクソ、ウェルカム、インコーポレーテッド Cckおよび/またはガストリン拮抗作用を有する1,5−ベンゾジアゼピン誘導体
GB2282595A (en) 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
GB2282594A (en) 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
AUPO284396A0 (en) 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6562807B2 (en) * 2000-06-23 2003-05-13 Novo Nordisk A/S Glucagon antagonists/inverse agonists
EP1443934B1 (en) 2001-11-13 2005-04-20 James Black Foundation Limited Benzotriazepines as gastrin and cholecystokinin receptor ligands
US7524837B2 (en) 2003-05-12 2009-04-28 Janssen Pharmaceutica N.V. Benzotriazapinone salts and methods for using same
WO2005090319A1 (en) 2004-03-19 2005-09-29 Arrow Therapeutics Limited Process for preparing benzodiazepines
FR2878849B1 (fr) * 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives

Similar Documents

Publication Publication Date Title
SK15892000A3 (sk) Spôsob syntézy cox-2 inhibítorov a medziprodukty
JP6832946B2 (ja) キナーゼ阻害剤およびその中間体の調製方法
WO2009053808A2 (en) Histone deacetylase inhibitors
JP2008514610A5 (https=)
TW201609679A (zh) 磷脂酸肌醇-3-激酶抑制劑的製造方法
CA3108974A1 (en) Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
FR2943669A1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
Milen et al. Propylphosphonic anhydride (T3P®) mediated one-pot three-component synthesis of racemic dialkyl (2-substituted-3-oxo-2, 3-dihydro-1H-isoindol-1-yl) phosphonates
JP2022521859A5 (https=)
Krawczyk et al. A convenient synthesis and cytotoxic evaluation of N-unsubstituted α-methylene-γ-lactams
Aali et al. 1-Disulfo-[2, 2-bipyridine]-1, 1-diium chloride ionic liquid as an efficient catalyst for the green synthesis of 5-substituted 1H-tetrazoles
AU2008309269A1 (en) Novel histone deacetylase inhibitors
JP2018523660A5 (https=)
JPS6058747B2 (ja) アミノ化合物の製法
Gao et al. Synthesis of functionalized 5-substituted thiazolidine-2-thiones via adscititious xanthate-promoted radical cyclization of allyl (alkyl/aryl) dithiocarbamates
CA3151407A1 (en) Indole carboxamide compounds and use thereof for the treatment of mycobacterial infections
IL187832A (en) Intermediates for the preparation of optionally radio- labeled imatinib and process for their preparation
JP6009851B2 (ja) 1h−テトラゾール誘導体の製造方法
Giorgi et al. Chemoselective opening of Vince lactam epoxide with nitrogen nucleophiles
KR100586671B1 (ko) 5-치환 옥사졸 화합물 및 5-치환 이미다졸 화합물의제조방법
Dai et al. Highly chemoselective acylation of substituted aminophenols with 3-(trimethylacetyl)-1, 3-thiazolidine-2-thione
JP2022513215A5 (https=)
KR20240125858A (ko) 신규 화합물 및 이를 포함하는 약학 조성물
CN118084923A (zh) 作为lrrk2激酶抑制剂的环状化合物及其制备方法
CN120623148A (zh) 一种c-Myc降解剂及其制备方法和用途